AGP Picks
View all

LATAM Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.

Press releases published on May 7, 2026

NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights
LiveRamp to Discuss Fourth Quarter FY26 Financial Results
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
Phunware Reports First Quarter 2026 Financial Results
AvePoint Announces First Quarter 2026 Financial Results
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
CarGurus Announces First Quarter 2026 Results
Definitive Healthcare Reports Financial Results for First Quarter 2026
 Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
EverCommerce Announces First Quarter 2026 Financial Results
Atsena Presents Positive Clinical Data from Its XLRS and LCA1 Gene Therapy Programs at ARVO 2026
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
Silvaco Reports First Quarter 2026 Financial Results
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

LATAM Technology Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.